Time to Rein in the Drug-Industry Middlemen Exploiting Patients

Last month, lawmakers missed a big chance to lower the cost of prescription medicine.


Despite including a host of new drug-pricing measures in the Inflation Reduction Act (IRA), legislators did almost nothing to crack down on some of the worst actors in the entire healthcare system — the "pharmacy benefit managers" and other supply-chain intermediaries who routinely raise drug costs and deny consumers access to life saving drugs.


Read the full piece >